IN2014DN07019A - - Google Patents
Info
- Publication number
- IN2014DN07019A IN2014DN07019A IN7019DEN2014A IN2014DN07019A IN 2014DN07019 A IN2014DN07019 A IN 2014DN07019A IN 7019DEN2014 A IN7019DEN2014 A IN 7019DEN2014A IN 2014DN07019 A IN2014DN07019 A IN 2014DN07019A
- Authority
- IN
- India
- Prior art keywords
- positive
- methods
- cancer
- mammalian subject
- diagnosing
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70589—CD45
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Sampling And Sample Adjustment (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261590066P | 2012-01-24 | 2012-01-24 | |
| US201361753665P | 2013-01-17 | 2013-01-17 | |
| PCT/IB2013/050547 WO2013111054A1 (fr) | 2012-01-24 | 2013-01-22 | Méthodes de détection de cellules tumorales circulantes 5t4-positives et méthodes de diagnostic d'un cancer 5t4-positif chez un sujet mammifère |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN07019A true IN2014DN07019A (fr) | 2015-04-10 |
Family
ID=47844410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7019DEN2014 IN2014DN07019A (fr) | 2012-01-24 | 2013-01-22 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10254286B2 (fr) |
| EP (1) | EP2807485B1 (fr) |
| JP (1) | JP6254951B2 (fr) |
| KR (1) | KR101716555B1 (fr) |
| CN (1) | CN104094116B (fr) |
| AU (2) | AU2013213301A1 (fr) |
| BR (1) | BR112014018192A8 (fr) |
| CA (1) | CA2861437C (fr) |
| ES (1) | ES2724232T3 (fr) |
| HK (1) | HK1202923A1 (fr) |
| IL (1) | IL233543B (fr) |
| IN (1) | IN2014DN07019A (fr) |
| MX (1) | MX361058B (fr) |
| RU (1) | RU2646498C2 (fr) |
| WO (1) | WO2013111054A1 (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2661735T3 (es) | 2009-10-21 | 2018-04-03 | The Scripps Research Institute | Método para usar células no raras para detectar células raras |
| US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
| US20150185204A1 (en) * | 2013-12-30 | 2015-07-02 | The Scripps Research Institute | Circulating tumor cell diagnostics for lung cancer |
| WO2015112955A1 (fr) | 2014-01-27 | 2015-07-30 | Epic Sciences, Inc. | Diagnostics de cellules tumorales circulantes pour biomarqueurs du cancer de la prostate |
| WO2015127008A1 (fr) * | 2014-02-21 | 2015-08-27 | Epic Sciences, Inc. | Méthodes pour analyser des cellules circulantes rares |
| WO2015155345A1 (fr) * | 2014-04-11 | 2015-10-15 | Medimmune Limited | Anticorps et conjugués anticorps-médicament |
| EP3140656B1 (fr) * | 2014-05-09 | 2021-02-17 | The Scripps Research Institute | Compositions et procédés de biopsie de liquides permettant le diagnostic de mélanome |
| WO2016033103A1 (fr) * | 2014-08-25 | 2016-03-03 | Creatv Microtech, Inc. | Utilisation de biomarqueurs de cellules circulant dans le sang pour la détection et le diagnostic de maladies, et leurs procédés d'isolement |
| CN113552350A (zh) * | 2015-04-21 | 2021-10-26 | 基因泰克公司 | 用于前列腺癌分析的组合物和方法 |
| KR102406596B1 (ko) * | 2016-02-23 | 2022-06-10 | 노을 주식회사 | 패치를 이용하는 ctc 진단 방법 및 장치 |
| KR20170099737A (ko) * | 2016-02-23 | 2017-09-01 | 노을 주식회사 | 접촉식 염색 패치 및 이를 이용하는 염색 방법 |
| US10371610B2 (en) | 2016-02-23 | 2019-08-06 | Noul Co., Ltd. | Contact-type patch, staining method using the same, and manufacturing method thereof |
| KR102045068B1 (ko) * | 2016-02-23 | 2019-11-15 | 노을 주식회사 | 중합 효소 연쇄 반응 패치, 이를 이용하는 진단 방법 및 장치 |
| CA3055132A1 (fr) | 2017-04-03 | 2018-10-11 | F. Hoffmann-La Roche Ag | Anticorps se liant a steap-1 |
| CN111033238A (zh) * | 2017-06-27 | 2020-04-17 | 定量癌症诊断有限责任公司 | 定量的液体活检诊断系统与方法 |
| CN107918013A (zh) * | 2017-09-25 | 2018-04-17 | 浙江天科高新技术发展有限公司 | 化学发光酶免测定循环肿瘤细胞中K‑Ras蛋白的方法及试剂盒 |
| JP2019195304A (ja) | 2018-05-10 | 2019-11-14 | 学校法人順天堂 | 画像解析方法、装置、コンピュータプログラム、及び深層学習アルゴリズムの生成方法 |
| US20220002429A1 (en) * | 2018-10-24 | 2022-01-06 | Northwestern University | Tumor cell aggregation inhibitors' for treating cancer |
| JP7381003B2 (ja) * | 2019-04-26 | 2023-11-15 | 学校法人順天堂 | 疾患解析を支援する方法、装置、及びコンピュータプログラム、並びにコンピュータアルゴリズムを訓練する方法、装置、及びプログラム |
| WO2023107566A1 (fr) | 2021-12-07 | 2023-06-15 | Epic Sciences, Inc. | Caractérisation améliorée du cancer du sein |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4391904A (en) | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein |
| AU3353989A (en) | 1988-03-04 | 1989-09-22 | Cancer Research Campaign Technology Limited | Improvements relating to antigens |
| US5869053A (en) | 1988-03-04 | 1999-02-09 | Cancer Research Campaign Technology, Ltd. | 5T4 antigen from human trophoblasts |
| EP1012259B1 (fr) | 1997-06-04 | 2009-09-30 | Oxford Biomedica (UK) Limited | Vecteur ciblant les tumeurs |
| AU1290001A (en) | 1999-11-18 | 2001-05-30 | Oxford Biomedica (Uk) Limited | Antibodies |
| GB0126378D0 (en) | 2001-11-02 | 2002-01-02 | Oxford Biomedica Ltd | Antigen |
| US7305112B2 (en) | 2002-10-15 | 2007-12-04 | The Scripps Research Institute | Method of converting rare cell scanner image coordinates to microscope coordinates using reticle marks on a sample media |
| BRPI0515113A (pt) * | 2004-09-10 | 2008-07-01 | Wyeth Corp | anticorpos anti-5t4 humanizados e conjugados de anticorpo anti-5t4/caliqueamicina |
| US20090317836A1 (en) | 2006-01-30 | 2009-12-24 | The Scripps Research Institute | Methods for Detection of Circulating Tumor Cells and Methods of Diagnosis of Cancer in Mammalian Subject |
| ES2712942T3 (es) | 2006-03-10 | 2019-05-16 | Wyeth Llc | Anticuerpos anti-5T4 y usos de los mismos |
| US20100233693A1 (en) | 2007-04-16 | 2010-09-16 | On-O-ity, Inc | Methods for diagnosing, prognosing, or theranosing a condition using rare cells |
| GB0822836D0 (en) * | 2008-12-15 | 2009-01-21 | Oxford Biomedica Ltd | Method |
| JP5923035B2 (ja) | 2009-03-24 | 2016-05-24 | バイオセプト インコーポレイティッド | 細胞の捕捉および解析のデバイスおよび方法 |
| US9340774B2 (en) | 2009-03-27 | 2016-05-17 | Wyeth Llc | Tumor-initiating cells and methods for using same |
| CN102482703A (zh) | 2009-09-03 | 2012-05-30 | 斯克里普斯研究所 | 对循环肿瘤细胞进行分类的方法 |
| ES2661735T3 (es) | 2009-10-21 | 2018-04-03 | The Scripps Research Institute | Método para usar células no raras para detectar células raras |
| JP2013526852A (ja) * | 2010-04-06 | 2013-06-27 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス | 疾患に対する循環バイオマーカー |
| EP2591363B1 (fr) * | 2010-07-07 | 2017-09-20 | The Regents Of The University Of Michigan | Diagnostic et traitement du cancer du sein |
| WO2012131527A1 (fr) | 2011-04-01 | 2012-10-04 | Wyeth Llc | Conjugués anticorps-médicament |
-
2013
- 2013-01-22 US US14/374,083 patent/US10254286B2/en not_active Expired - Fee Related
- 2013-01-22 CN CN201380006333.9A patent/CN104094116B/zh not_active Expired - Fee Related
- 2013-01-22 KR KR1020147020394A patent/KR101716555B1/ko active IP Right Grant
- 2013-01-22 EP EP13708526.2A patent/EP2807485B1/fr active Active
- 2013-01-22 MX MX2014008928A patent/MX361058B/es active IP Right Grant
- 2013-01-22 CA CA2861437A patent/CA2861437C/fr not_active Expired - Fee Related
- 2013-01-22 ES ES13708526T patent/ES2724232T3/es active Active
- 2013-01-22 BR BR112014018192A patent/BR112014018192A8/pt not_active Application Discontinuation
- 2013-01-22 JP JP2014553836A patent/JP6254951B2/ja not_active Expired - Fee Related
- 2013-01-22 AU AU2013213301A patent/AU2013213301A1/en not_active Abandoned
- 2013-01-22 IN IN7019DEN2014 patent/IN2014DN07019A/en unknown
- 2013-01-22 RU RU2014127474A patent/RU2646498C2/ru active
- 2013-01-22 WO PCT/IB2013/050547 patent/WO2013111054A1/fr active Application Filing
-
2014
- 2014-07-07 IL IL233543A patent/IL233543B/en active IP Right Grant
-
2015
- 2015-04-08 HK HK15103408.3A patent/HK1202923A1/xx not_active IP Right Cessation
-
2018
- 2018-08-24 AU AU2018220154A patent/AU2018220154A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018220154A1 (en) | 2018-09-13 |
| AU2013213301A1 (en) | 2014-07-17 |
| RU2014127474A (ru) | 2016-03-20 |
| JP6254951B2 (ja) | 2017-12-27 |
| ES2724232T3 (es) | 2019-09-09 |
| US20150017661A1 (en) | 2015-01-15 |
| CN104094116B (zh) | 2017-05-31 |
| CN104094116A (zh) | 2014-10-08 |
| CA2861437A1 (fr) | 2013-08-01 |
| MX361058B (es) | 2018-11-23 |
| CA2861437C (fr) | 2018-08-21 |
| EP2807485B1 (fr) | 2019-03-13 |
| EP2807485A1 (fr) | 2014-12-03 |
| KR101716555B1 (ko) | 2017-03-14 |
| HK1202923A1 (en) | 2015-10-09 |
| US10254286B2 (en) | 2019-04-09 |
| RU2646498C2 (ru) | 2018-03-05 |
| IL233543B (en) | 2018-02-28 |
| JP2015507190A (ja) | 2015-03-05 |
| IL233543A0 (en) | 2014-08-31 |
| KR20140100580A (ko) | 2014-08-14 |
| BR112014018192A8 (pt) | 2021-03-02 |
| MX2014008928A (es) | 2014-10-24 |
| WO2013111054A1 (fr) | 2013-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN07019A (fr) | ||
| EP2576837A4 (fr) | Biomarqueurs d'acides nucléiques circulants associés au cancer de la prostate | |
| MX2013000917A (es) | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. | |
| MY188938A (en) | Therapeutic, diagnostic and prognostic methods for cancer of the bladder | |
| IL230687A0 (en) | Methods for diagnosing cancer by characterizing cancer cells associated with pleural fluids or serum | |
| EP4219765A3 (fr) | Pronostic du cancer de la prostate à l'aide de biomarqueurs | |
| EP2524059A4 (fr) | Détection d'affections gastro-intestinales | |
| GB2545361A (en) | Protein biomarker panels for detecting colorectal cancer and advanced adenoma | |
| GB2519906A (en) | Methods and systems for detecting biological components | |
| MX2013002084A (es) | Biomarcadores y metodos de tratamiento. | |
| WO2007089911A3 (fr) | procedes de detection de cellules tumorales circulantes et procedes de diagnostic de cancer chez un sujet mammalien | |
| WO2013138522A3 (fr) | Méthodes d'évaluation de l'efficacité et de la surveillance d'un traitement viral oncolytique | |
| MY170983A (en) | Biomarker assays for detecting or measuring inhibition of tor kinase activity | |
| MX358117B (es) | Métodos y ácidos nucleicos para determinar el pronóstico de un sujeto con cáncer. | |
| HK1213946A1 (zh) | 用於使用 對前列腺癌轉移進行診斷、預後和治療的方法 | |
| WO2012012704A3 (fr) | Procédés de détection de maladies ou d'états associés au rein | |
| MX2016012697A (es) | Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales. | |
| WO2013036543A3 (fr) | Imagerie moléculaire de cellules cancéreuses in vivo | |
| EP3683321A3 (fr) | Procédés relatifs à des groupes de cellules tumorales circulantes et au traitement du cancer | |
| EP2971132A4 (fr) | Biomarqueurs de miarn à base de tissu et de sang pour le diagnostic, le pronostic et le potentiel prédictif de métastases dans le cancer colorectal | |
| NZ629555A (en) | Monocyte biomarkers for cancer detection | |
| WO2014078468A3 (fr) | Biomarqueurs destinés à prédire une réponse clinique de patients cancéreux suite à un traitement avec un agent immunothérapeutique | |
| EP2833149A4 (fr) | Procédé de détection du degré de malignité d'une unité de cellule tumorale circulante et trousse pour celui-ci | |
| WO2013081645A3 (fr) | Mutations dans erbb3 dans des cancers | |
| IN2014DN08312A (fr) |